STOCK ALARM
PRO
SA
PRO
Menu
⌘K
⌘J
Pro
Sign In
Free Account
Themes
Can-Fite BioPharma Ltd.
CANF
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
Financials
Growth
Insiders
Analysis
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Loading chart...
As of
2024
• vs 2023
Annual
Quarterly
Core Metrics
Market Cap
$34.04B
+19.5%
P/E Ratio
-4,320.26
-15.8%
P/S Ratio
50,509.82
+31.7%
ROE
-144.96%
-18.5%
ROIC
-114.17%
-11.4%
FCF Yield
-0.02%
+24.2%
Debt/Equity
0.02
+198.6%
Current Ratio
4.38
-10.8%
Interest Coverage
-580.71x
+0.8%
Per Share
Revenue/Share
$0.00
-46.7%
Net Income/Share
$-0.00
+39.4%
Operating CF/Share
$-0.00
+46.8%
Free CF/Share
$-0.00
+46.8%
Cash/Share
$0.00
-48.1%
Book Value/Share
$0.00
-48.8%
Tangible Book/Share
$0.00
-48.8%
Equity/Share
$0.00
-48.8%
Interest Debt/Share
$0.00
+28.4%
Valuation
Market Cap
$34.04B
+19.5%
Enterprise Value
$34.04B
+19.5%
P/E Ratio
-4,320.26
-15.8%
P/S Ratio
50,509.82
+31.7%
P/OCF Ratio
-4,457.72
-32.0%
P/FCF Ratio
-4,454.80
-32.0%
P/B Ratio
6,262.62
+37.2%
P/TB Ratio
6,262.62
+37.2%
EV/Sales
50,502.81
+31.7%
EV/EBITDA
-4,190.43
-20.3%
Profitability
Earnings Yield
-0.02%
+13.6%
FCF Yield
-0.02%
+24.2%
ROE
-144.96%
-18.5%
ROIC
-114.17%
-11.4%
Return on Tangible Assets
-86.40%
-13.1%
Capital Allocation
CapEx/OCF
-0.07%
-176.3%
CapEx/Revenue
0.74%
+175.6%
CapEx/Depreciation
0.71
+435.7%
SBC/Revenue
53.71%
+52.9%
Balance Sheet
Debt/Equity
0.02
+198.6%
Debt/Assets
0.01
+184.8%
Net Debt/EBITDA
0.58
+12.2%
Current Ratio
4.38
-10.8%
Interest Coverage
-580.71x
+0.8%
Income Quality
0.97
-12.3%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$0.00
-52.3%